EE200100179A - Farmatseutilised agendid Parkinsoni tõve, ADHD jamikroadenoomide raviks - Google Patents

Farmatseutilised agendid Parkinsoni tõve, ADHD jamikroadenoomide raviks

Info

Publication number
EE200100179A
EE200100179A EEP200100179A EEP200100179A EE200100179A EE 200100179 A EE200100179 A EE 200100179A EE P200100179 A EEP200100179 A EE P200100179A EE P200100179 A EEP200100179 A EE P200100179A EE 200100179 A EE200100179 A EE 200100179A
Authority
EE
Estonia
Prior art keywords
adenomas
adhd
microvascular
parkinson
disease
Prior art date
Application number
EEP200100179A
Other languages
English (en)
Estonian (et)
Inventor
Rose Jackson Elise
Mclean Stafford
Howard Zorn Stevin
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of EE200100179A publication Critical patent/EE200100179A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EEP200100179A 1998-09-21 1999-09-03 Farmatseutilised agendid Parkinsoni tõve, ADHD jamikroadenoomide raviks EE200100179A (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10119198P 1998-09-21 1998-09-21
US10386898P 1998-10-12 1998-10-12
PCT/IB1999/001503 WO2000016777A1 (en) 1998-09-21 1999-09-03 Pharmaceutical agents for the treatment of parkinson's disease, adhd and microadenomas

Publications (1)

Publication Number Publication Date
EE200100179A true EE200100179A (et) 2002-10-15

Family

ID=26798000

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200100179A EE200100179A (et) 1998-09-21 1999-09-03 Farmatseutilised agendid Parkinsoni tõve, ADHD jamikroadenoomide raviks

Country Status (38)

Country Link
US (2) US6300329B1 (id)
EP (1) EP1115402A1 (id)
JP (1) JP2002526448A (id)
KR (3) KR20030088512A (id)
CN (1) CN1319013A (id)
AP (1) AP1456A (id)
AR (1) AR029739A1 (id)
AU (1) AU760230B2 (id)
BG (1) BG105445A (id)
BR (1) BR9913975A (id)
CA (1) CA2344670A1 (id)
CO (1) CO5140075A1 (id)
CZ (1) CZ20011006A3 (id)
DZ (1) DZ2894A1 (id)
EA (2) EA200100204A1 (id)
EE (1) EE200100179A (id)
GE (1) GEP20033081B (id)
GT (1) GT199900154A (id)
HN (1) HN1999000146A (id)
HR (1) HRP20010209A2 (id)
HU (1) HUP0103691A3 (id)
ID (1) ID28028A (id)
IL (2) IL164839A0 (id)
IS (1) IS5852A (id)
MA (1) MA26690A1 (id)
MY (1) MY127939A (id)
NO (1) NO20011409L (id)
NZ (1) NZ509855A (id)
OA (1) OA11653A (id)
PA (1) PA8482001A1 (id)
PE (1) PE20001084A1 (id)
PL (1) PL346904A1 (id)
SK (1) SK3592001A3 (id)
TN (1) TNSN99177A1 (id)
TR (2) TR200402083T2 (id)
TW (1) TW518225B (id)
WO (1) WO2000016777A1 (id)
YU (1) YU21701A (id)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN1999000146A (es) * 1998-09-21 2000-11-11 Pfizer Prod Inc Agentes farmaceuticos para el tratamiento de la enfermedad de parkinson, adhd y microadenomas.
WO2001068104A1 (en) * 2000-03-16 2001-09-20 The Mclean Hospital Corporation Compounds for the treatment of psychiatric or substance abuse disorders
GB0027020D0 (en) * 2000-11-03 2000-12-20 Univ Manchester Treatment of movement disorders
US7053092B2 (en) 2001-01-29 2006-05-30 Otsuka Pharmaceutical Co., Ltd. 5-HT1a receptor subtype agonist
WO2002102988A2 (en) * 2001-06-18 2002-12-27 Psychiatric Genomics, Inc. Method for neural stem cell differentiation using 5ht-1a agonists
US20030036555A1 (en) * 2001-08-03 2003-02-20 Boehringer Ingelheim Pharma Kg Pramipexole for the treatment of ADHD
AR033485A1 (es) 2001-09-25 2003-12-26 Otsuka Pharma Co Ltd Sustancia medicinal de aripiprazol de baja higroscopicidad y proceso para la preparacion de la misma
WO2005122767A1 (en) * 2004-06-10 2005-12-29 Mclean Hospital Corporation Pyrimidines, such as uridine, in treatments for patients with bipolar disorder
US7947661B2 (en) * 2004-08-11 2011-05-24 The Mclean Hospital Corporation Compounds for the treatment of marihuana dependence, withdrawal, and usage
MY148644A (en) 2005-07-18 2013-05-15 Orion Corp New pharmaceutical compounds
PE20070523A1 (es) 2005-09-12 2007-06-28 Wyeth Corp Formulacion de liberacion sostenida del glucuronato de (8-{4-[3-(5-fluoro-1h-indol-3-il)-propil]-piperazin-1-il}-2-metil-4h-benzo[1,4]oxazin-3-ona
GT200600414A (es) 2005-09-12 2007-09-20 Sal de glucuranato de compuesto de piperazine
GT200600416A (es) 2005-09-12 2007-09-20 Sales salicilato y gentisato de un compuesto de piperazina
US9066903B2 (en) * 2006-02-28 2015-06-30 The United States Of America As Represented By The Department Of Veterans Affairs Pharmacological treatment of Parkinson's disease
US20080131492A1 (en) * 2006-06-23 2008-06-05 Spherics, Inc. Dosage forms for movement disorder treatment
WO2008083442A1 (en) * 2007-01-10 2008-07-17 Brc Operations Pty Limited Method for formulating combination medications for adhd
CN101318020B (zh) * 2007-06-06 2011-09-28 四川科瑞德制药有限公司 抗焦虑或/和抗抑郁的药物组合物及用途
US20100041621A1 (en) * 2008-08-15 2010-02-18 Perry Renshaw Methods and compositions for improving cognitive performance
GB201112987D0 (en) 2011-07-28 2011-09-14 Ge Healthcare Ltd Novel compound
US10154988B2 (en) 2012-11-14 2018-12-18 The Johns Hopkins University Methods and compositions for treating schizophrenia
US9463186B2 (en) 2013-04-15 2016-10-11 Northwestern University Treatment for dopaminergic disorders
CN104892589A (zh) 2014-03-07 2015-09-09 中国科学院上海药物研究所 一类杂环化合物、其制备方法和用途
US11426366B2 (en) 2015-05-15 2022-08-30 Arizona Board Of Regents On Behalf Of The Universsity Of Arizona Compositions and methods for treating motor disorders

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990008148A1 (en) * 1989-01-23 1990-07-26 Pfizer Inc. Bis-aza-bicyclic anxiolytic agents
WO1992000075A1 (en) * 1990-06-29 1992-01-09 Pfizer Inc. Pyridopyrazine derivatives for treating substance abuse and addiction
US5281607B1 (en) * 1992-10-08 1998-05-19 Univ New York Method of using alpha 2-antagonists for the treatment of neurodegenerative diseases
GB9408084D0 (en) * 1994-04-23 1994-06-15 Boots Co Plc Medical treatment
WO1995034555A1 (en) * 1994-06-14 1995-12-21 Pfizer Inc. Benzimidazolone derivatives with central dopaminergic activity
US5877183A (en) * 1996-06-06 1999-03-02 Ergo Research Corporation Treatment of lipid and glucose metabolism disorders with dopamine and serotonin agonists
HN1999000146A (es) * 1998-09-21 2000-11-11 Pfizer Prod Inc Agentes farmaceuticos para el tratamiento de la enfermedad de parkinson, adhd y microadenomas.

Also Published As

Publication number Publication date
TR200101357T2 (tr) 2001-08-21
IL164839A0 (en) 2005-12-18
TNSN99177A1 (fr) 2005-11-10
HRP20010209A2 (en) 2002-04-30
KR20030088512A (ko) 2003-11-19
EA200100204A1 (ru) 2001-08-27
PL346904A1 (en) 2002-03-11
BR9913975A (pt) 2001-06-19
CN1319013A (zh) 2001-10-24
NO20011409D0 (no) 2001-03-20
US20010034347A1 (en) 2001-10-25
WO2000016777A1 (en) 2000-03-30
PA8482001A1 (es) 2000-05-24
KR100468340B1 (ko) 2005-01-27
BG105445A (en) 2001-12-29
EP1115402A1 (en) 2001-07-18
HUP0103691A3 (en) 2003-01-28
ID28028A (id) 2001-05-03
US6300329B1 (en) 2001-10-09
IS5852A (is) 2001-02-20
YU21701A (sh) 2004-07-15
US6608064B2 (en) 2003-08-19
PE20001084A1 (es) 2000-10-18
TW518225B (en) 2003-01-21
AU5383199A (en) 2000-04-10
MA26690A1 (fr) 2004-12-20
KR20040054752A (ko) 2004-06-25
GEP20033081B (en) 2003-10-27
KR20010075222A (ko) 2001-08-09
AR029739A1 (es) 2003-07-16
HN1999000146A (es) 2000-11-11
DZ2894A1 (fr) 2003-12-15
CO5140075A1 (es) 2002-03-22
GT199900154A (es) 2001-03-06
SK3592001A3 (en) 2001-12-03
TR200402083T2 (tr) 2004-10-21
IL141507A0 (en) 2002-03-10
EA200301063A1 (ru) 2004-12-30
CZ20011006A3 (cs) 2001-09-12
JP2002526448A (ja) 2002-08-20
NZ509855A (en) 2003-04-29
CA2344670A1 (en) 2000-03-30
AU760230B2 (en) 2003-05-08
NO20011409L (no) 2001-03-28
HUP0103691A2 (hu) 2002-02-28
AP1456A (en) 2005-09-30
OA11653A (en) 2004-12-08
AP2001002102A0 (en) 2001-03-31
MY127939A (en) 2007-01-31

Similar Documents

Publication Publication Date Title
CY2020003I1 (el) Anti-il-12 αντισωματα, συνθεσεις, μεθοδοι και χρησεις για την θεραπευτικη αγωγη της παθολογιας του crohn
CY2018020I1 (el) Θεραπεια της νοσου ρομρε
DE69929996D1 (de) Pharmazeutisches mittel zur behandlung von diabetes
FI20000720A7 (fi) Pitkitettyyn vapautumiseen perustuva tablettiformulaatio Parkisonin taudin hoitamiseksi
PL346904A1 (en) Pharmaceutical agents for the treatment of parkinson's disease, adhd and microadenomas
PT1233973E (pt) Derivados de adenosina n6-heterociclicos 5'-tio-substituida agonistas parciais ou totais de a1
BR9804500B1 (pt) derivado de amida, referida composição farmacêutica e agente terapêutico.
ATE447947T1 (de) Pharmazeutische zubereitungen zur behandlung von insulinresitenz
IT1306553B1 (it) Procedimento e dispositivo per la determinazione dell'interasse deiveicoli sterzanti.
PT1154777E (pt) Medicamento para o tratamento de hipertensao arterial
NO20001869D0 (no) Fremgangsmõte for behandling av Alzheimerssykdom
NO20003229L (no) Kombinasjon av benzosykloheptapyridinforbindelser og antineoplastiske midler for behandling av proliferaktive sykdommer
EE04263B1 (et) Farmatseutiline kompositsioon piperidinoalkanoolantihistamiini ja selle derivaatide biosaadavuse suurendamiseks ning allergiliste reaktsioonide raviks patsiendil
DE69838785D1 (de) Pharmazeutische mittel zur behandlung von zerebralen amyloidosis
NO20012106D0 (no) Middel for behandling av benpatobolisme
DE60023003D1 (de) Haarbehandlungsmittel
ATE314064T1 (de) L-acetylcarnitin und l-propionylcarnitin zusammensetzung zur verhütung und behandlung von nierenstörungen und nierenenkrankheit
ID30458A (id) Osanetan dalam pengobatan gangguan jiwa
NO20012612L (no) Isonipecotamider for behandlingen av integrin-formidlede sykdommer
IT1319105B1 (it) Procedimento per fabbricare opuscoli e dispositivo per l'esecuzionedel procedimento
PT1064014E (pt) Medicamento para o impedimento ou tratamento de tumores especificos de papilomavirus
ID28817A (id) Penggunaan turunan-turunan tetrahidropiridin (atau4-hidropiperidin)-butilazol dalam pembuatan obat untuk perawatan nyeri
FR2777566B1 (fr) Derives d'azacycloalcanes, leur preparation et leur application en therapeutique
IT1320401B1 (it) Procedimento per la fabbricazione di componenti di un'ossatura ecomponenti di ossatura.
ZA200102029B (en) Pharmaceutical agents for the treatment of Parkinson's disease, ADHD and microadenomas.